Company intelligence / Profile preview

Quicksilver Group

Louisville, Colorado, United Statesquicksilvergroup.com.au ↗

Ownership: Private
Employees: ~65
Development stage: Other

Overview

Quicksilver Scientific has developed over 60 advanced liposomal supplements and more than 20 protocols for detoxification, cognitive health, mitochondrial function, and overall wellness. Their products are widely used by healthcare practitioners globally. They have proprietary delivery systems that increase bioavailability of nutrients such as glutathione and magnesium L-threonate. Clinical collaborations are ongoing with major academic institutions; flagship products like NAD+ Platinum™ have shown strong market adoption in the longevity space.

Therapeutic areas: Metabolic DisordersNeurologyOther
Modalities: Liposomal supplementSmall molecule
Industry: Food & Nutrition

Partnerships

Life Extension Europe (distribution partnership)

Beyond the preview

Go deeper on Quicksilver Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quicksilver Group.

Explore the full profile